The best indicator for Keurig Dr Pepper (KDP)
We backtested 20 indicators across daily, weekly and hourly charts on real Keurig Dr Pepper (KDP) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
WaveTrend (8/6/4)
On the weekly chart, this is the strongest risk-adjusted edge we found for Keurig Dr Pepper (KDP) over ~18.2 years — trailing buy-and-hold by 6.7% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | WaveTrend (8/6/4) ✓ | Weekly | 7.7% | 0.66 | -28.0% | 87.5% | 16 | -6.7% |
| 2 | Donchian Breakout | Daily | 8.2% | 0.56 | -27.4% | 50.0% | 70 | -6.2% |
| 3 | SMA 50/200 Cross | Daily | 8.7% | 0.55 | -44.3% | 57.1% | 14 | -5.7% |
| 4 | WaveTrend (8/6/4) ✓ | Daily | 7.4% | 0.5 | -40.9% | 70.3% | 64 | -7.0% |
| 5 | RSI Mean-Reversion ✓ | Daily | 3.8% | 0.49 | -21.0% | 87.0% | 23 | -10.5% |
| 6 | Stochastic ✓ | Daily | 6.1% | 0.47 | -34.0% | 71.6% | 88 | -8.3% |
| 7 | EMA 50/200 Cross | Daily | 11.7% | 0.68 | -27.6% | 50.0% | 10 | -2.7% |
| 8 | Williams %R ✓ | Daily | 6.1% | 0.45 | -32.9% | 71.2% | 125 | -8.3% |
| 9 | Stochastic ✓ | Weekly | 5.0% | 0.45 | -28.0% | 86.7% | 15 | -9.4% |
| 10 | EMA 20/50 Cross | Daily | 6.1% | 0.42 | -52.6% | 38.3% | 47 | -8.3% |
| 11 | Williams %R ✓ | Weekly | 4.8% | 0.4 | -46.7% | 84.6% | 26 | -9.5% |
| 12 | CCI ✓ | Weekly | 3.3% | 0.3 | -46.7% | 78.9% | 19 | -11.1% |
| 13 | ADX / DMI | Daily | 3.3% | 0.29 | -37.2% | 39.5% | 114 | -11.0% |
| 14 | Bollinger Mean-Reversion | Daily | 3.1% | 0.28 | -37.7% | 69.3% | 75 | -11.3% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Keurig Dr Pepper (KDP), WaveTrend (8/6/4) on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.